Miriam K. Forbes, PhD


Efficacy, safety, and durability of repeated ketamine infusions for comorbid posttraumatic stress disorder and treatment-resistant depression


Journal article


C.S. Albott, K.O. Lim, M.K. Forbes, C. Erbes, S.J. Tye, J.G. Grabowski, P. Thuras, T.M. Batres-Y-Carr, J. Wels, P.R. Shiroma
Journal of Clinical Psychiatry, 2018

Cite
close

Cite

APA
Albott, C. S., Lim, K. O., Forbes, M. K., Erbes, C., Tye, S. J., Grabowski, J. G., … Shiroma, P. R. (2018). Efficacy, safety, and durability of repeated ketamine infusions for comorbid posttraumatic stress disorder and treatment-resistant depression. Journal of Clinical Psychiatry, 79.

Chicago/Turabian
Albott, C.S., K.O. Lim, M.K. Forbes, C. Erbes, S.J. Tye, J.G. Grabowski, P. Thuras, T.M. Batres-Y-Carr, J. Wels, and P.R. Shiroma. “Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression.” Journal of Clinical Psychiatry 79 (2018).

MLA
Albott, C. S., et al. “Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression.” Journal of Clinical Psychiatry, vol. 79, 2018.